Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT

NCT03233243 is registered in ClinicalTrials.gov with University of Coimbra as lead sponsor.

NCT NCT03233243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03233243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT
Lead sponsor
University of Coimbra
Phase
Phase 4
Overall status
Completed
Start date
July 27, 2020
Completion date
October 27, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, molecular imaging